Received Jun 2, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 1 | US-VIV 2300013 | PO / MO |
Severe allergic reaction, onset approximately 5-7 minutes following ingestion of the oral capsule. Symptoms began with tingling in the mouth/throat, and quickly progress to difficulties breathing within a minute. EpiPen was administered quickly, less than 5 minutes after the reaction started. Patient was conscious and showing minimal symptoms when ambulance arrived. Patient was transferred a local ER, and was given intravenous methylprednisone, diphenhydramine, and fomatidine. Patient was monitored for approximately 4 hours, and no further events or complications occurred. Patient was sent home with a 5-day course of prednisone, and instructions to take OTC Benadryl as needed for at least 5 days.
None
None
Loratidine 10mg (Claritin), Adderall XR 10mg
Unknown ingredient in Vivotif typhoid oral vaccine. None known prior to this event.
Blood was taken at the ER (5/29/2025), still waiting for my medical records to be transferred to see if they actually ran bloodwork.